Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Abbisko, Alterity, Aum, Beijing Luzhu, Biophytis, Brii, Caliway, Canbridge, Connect, Harbour, Revive, Structure.

Biopharmas in Asia-Pacific raising money in public or private financings: Immutep, Invox, Lynk, Phion, Sino.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Mesoblast, Obi.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Anew, Ascendis, Biogen, BMS, Denali, Eureka, Idorsia, Medic, Searchlight, Sol-Gel.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akero, Amolyt, Astrazeneca, Bellerophon, Endo, Enterin, Fogpharma, Harbour, IGM, Immuneering, Newamsterdam, Ractigen, Sirnaomics, Synlogic, Tonix, Vaxess, Vivavision, Walden.

Biopharmas raising money in public or private financings, including: Acepodia, Azitra, Lexicon, Thryv, Zura.

New hires and promotions in the biopharma industry, including: Carmot, Cellarity, Essa, Janux, Kallyope, Kronos, T-Curx.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Galderma, Masimo, Sparrow Bioacoustics.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ceres, Biocorp, Clario, Eresearchtechnology, Medtronic, Novo Nordisk, Rockley, Sensydia, Titan.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Freestyle Partners, Gencurix, Grail.